The action affects more than 4.6 million doses, but the vast majority have already been used, according to the Food and Drug Administration. Agency officials said the vaccine was strong enough when it was distributed in October and November.
“The slight decrease in potency is not expected to have any effect on the protective effect of the vaccine,” said Norman Baylor, director of the FDA’s vaccine research office. “We are not recommending revaccination.”
Notice the same claim by the manufacturer – an effort to reassure those who were hoodwinked into getting the vaccine?
Maryland-based MedImmune, a subsidiary of London-based AstraZeneca PLC, voluntarily recalled 13 lots of its vaccine, “due to a slight decrease in potency” discovered through routine quality control testing, said spokesman Tor Constantino.
“It’s not a safety concern. People who have received doses from the affected lots do not need to be revaccinated. The doses were well within potency specification,” he said. (Source: Fox News)
If they were within the potency spec then why the recall? Perhaps it was just to keep people fearful of a “fake” pandemic?
Related articles by Zemanta
- Inside the $7 Billion Swine Flu Vaccine Industry (blogs.wsj.com)
- Poll finds 3/4 of parents who tried to get H1N1 vaccine for their children have gotten it (scienceblog.com)
- Obama Administration Admits H1N1 Mistakes (freedomeden.blogspot.com)